Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 Feb 9;160(3):365–371.

Prostate cancer: 10. Palliative care

N A Iscoe 1, E Bruera 1, R C Choo 1
PMCID: PMC1230043  PMID: 10065082

Full Text

The Full Text of this article is available as a PDF (207.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcangeli G., Micheli A., Arcangeli G., Giannarelli D., La Pasta O., Tollis A., Vitullo A., Ghera S., Benassi M. The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief. Radiother Oncol. 1989 Feb;14(2):95–101. doi: 10.1016/0167-8140(89)90053-4. [DOI] [PubMed] [Google Scholar]
  2. Ben-Josef E., Lucas D. R., Vasan S., Porter A. T. Selective accumulation of strontium-89 in metastatic deposits in bone: radio-histological correlation. Nucl Med Commun. 1995 Jun;16(6):457–463. doi: 10.1097/00006231-199506000-00007. [DOI] [PubMed] [Google Scholar]
  3. Blitzer P. H. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer. 1985 Apr 1;55(7):1468–1472. doi: 10.1002/1097-0142(19850401)55:7<1468::aid-cncr2820550708>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  4. Bloomfield D. J. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. J Clin Oncol. 1998 Mar;16(3):1218–1225. doi: 10.1200/JCO.1998.16.3.1218. [DOI] [PubMed] [Google Scholar]
  5. Bruera E., Schoeller T., Wenk R., MacEachern T., Marcelino S., Hanson J., Suarez-Almazor M. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage. 1995 Jul;10(5):348–355. doi: 10.1016/0885-3924(95)00052-z. [DOI] [PubMed] [Google Scholar]
  6. Bruera E., Velasco-Leiva A., Spachynski K., Fainsinger R., Miller M. J., MacEachern T. Use of the Edmonton Injector for parenteral opioid management of cancer pain: a study of 100 consecutive patients. J Pain Symptom Manage. 1993 Nov;8(8):525–528. doi: 10.1016/0885-3924(93)90081-6. [DOI] [PubMed] [Google Scholar]
  7. Buchali K., Correns H. J., Schuerer M., Schnorr D., Lips H., Sydow K. Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med. 1988;14(7-8):349–351. doi: 10.1007/BF00254382. [DOI] [PubMed] [Google Scholar]
  8. Cole D. J. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol (R Coll Radiol) 1989 Nov;1(2):59–62. doi: 10.1016/s0936-6555(89)80035-4. [DOI] [PubMed] [Google Scholar]
  9. Eisenberg D. M., Davis R. B., Ettner S. L., Appel S., Wilkey S., Van Rompay M., Kessler R. C. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998 Nov 11;280(18):1569–1575. doi: 10.1001/jama.280.18.1569. [DOI] [PubMed] [Google Scholar]
  10. Ernst D. S., Brasher P., Hagen N., Paterson A. H., MacDonald R. N., Bruera E. A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain. J Pain Symptom Manage. 1997 Jun;13(6):319–326. doi: 10.1016/s0885-3924(97)00075-4. [DOI] [PubMed] [Google Scholar]
  11. Fitzpatrick P. J., Rider W. D. Half body radiotherapy. Int J Radiat Oncol Biol Phys. 1976 Jan-Feb;1(3-4):197–207. doi: 10.1016/0360-3016(76)90041-9. [DOI] [PubMed] [Google Scholar]
  12. Fontanarosa P. B., Lundberg G. D. Alternative medicine meets science. JAMA. 1998 Nov 11;280(18):1618–1619. doi: 10.1001/jama.280.18.1618. [DOI] [PubMed] [Google Scholar]
  13. Lewington V. J., McEwan A. J., Ackery D. M., Bayly R. J., Keeling D. H., Macleod P. M., Porter A. T., Zivanovic M. A. A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone. Eur J Cancer. 1991;27(8):954–958. doi: 10.1016/0277-5379(91)90257-e. [DOI] [PubMed] [Google Scholar]
  14. Madsen E. L. Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy X 6 versus 10 Gy X 2. Int J Radiat Oncol Biol Phys. 1983 Dec;9(12):1775–1779. doi: 10.1016/0360-3016(83)90343-7. [DOI] [PubMed] [Google Scholar]
  15. Pereira J., Hanson J., Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer. 1997 Feb 15;79(4):835–842. [PubMed] [Google Scholar]
  16. Porter A. T., Ben-Josef E. Strontium 89 in the treatment of bony metastases. Important Adv Oncol. 1995:87–94. [PubMed] [Google Scholar]
  17. Porter A. T., McEwan A. J., Powe J. E., Reid R., McGowan D. G., Lukka H., Sathyanarayana J. R., Yakemchuk V. N., Thomas G. M., Erlich L. E. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):805–813. doi: 10.1016/0360-3016(93)90309-j. [DOI] [PubMed] [Google Scholar]
  18. Price P., Hoskin P. J., Easton D., Austin D., Palmer S. G., Yarnold J. R. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986 Aug;6(4):247–255. doi: 10.1016/s0167-8140(86)80191-8. [DOI] [PubMed] [Google Scholar]
  19. Quilty P. M., Kirk D., Bolger J. J., Dearnaley D. P., Lewington V. J., Mason M. D., Reed N. S., Russell J. M., Yardley J. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol. 1994 Apr;31(1):33–40. doi: 10.1016/0167-8140(94)90411-1. [DOI] [PubMed] [Google Scholar]
  20. Salazar O. M., Rubin P., Hendrickson F. R., Poulter C., Zagars G., Feldman M. I., Asbell S., Doss L. Single-dose half-body irradiation for the palliation of multiple bone metastases from solid tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 1981 Jun;7(6):773–781. doi: 10.1016/0360-3016(81)90472-7. [DOI] [PubMed] [Google Scholar]
  21. Tong D., Gillick L., Hendrickson F. R. The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group. Cancer. 1982 Sep 1;50(5):893–899. doi: 10.1002/1097-0142(19820901)50:5<893::aid-cncr2820500515>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  22. Zelefsky M. J., Scher H. I., Forman J. D., Linares L. A., Curley T., Fuks Z. Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1281–1285. doi: 10.1016/0360-3016(89)90537-3. [DOI] [PubMed] [Google Scholar]
  23. Zelefsky M. J., Scher H. I., Krol G., Portenoy R. K., Leibel S. A., Fuks Z. Y. Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy. Cancer. 1992 Nov 1;70(9):2319–2325. doi: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES